Anticardiolipin and anti-beta-2-glycoprotein I antibodies

References

• More JE, Lutz WB. Natural history of systemic lupus erythematosus: approach to its study through chronic biologic false positive reactors. J Chronic Dis 1955;1:297–316.
   PubMedGoogle Scholar
• Pangborn MC. A new serological active phospholipid from beef heart. Proc Soc Exp Biol Med 1941;48:484–486.
   Google Scholar
• Laurell AB, Nilsson IM. Hypergammablobulinemia, circulat-ing anticoagulant and biological false positive Wassermann reaction: a study of two cases. J Lab Clin Med 1957;49: 694–707.
   PubMed Web of Science ®Google Scholar
• Lee SL, Sanders M. A disorder of blood coagulation in systemiclupus erythematosus. J Clin Investig 1955;34: 1814–1822.
   PubMedGoogle Scholar
• Harris EN, Gharavi AE, Boey ML, Patel BM, Mackworth-Young CG, Loizou S, et al. Anticardiolipin antibodies: detection by radioimmunoassay and association with throm-bosisin systemic lupus erythematosus. Lancet 1983;2(8361): 1211–1214.
   Google Scholar
• Shoenfeld Y. Systemic antiphospholipid syndrome. Lupus 2003;12:497–498.
   PubMed Web of Science ®Google Scholar
• Loizou S, McCrea JD, Rudge A, Reynolds A, Boyle CC, Harris EN. Measurement of anticardiolipin antibodies by an enzyme-linked immunosorbent assay (ELISA): standardi-zation and quantitation of results. Clin Exp Immunol 1985;62:738–745.
   PubMed Web of Science ®Google Scholar
• Wilson W, Gharavi A, Koike T, Lockshin MD, Branch DW, Piette JC, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 1999;42:1309–1311.
   PubMed Web of Science ®Google Scholar
• Roubey RAS. Immunology of the antiphospholipid antibody syndrome. Arthritis Rheum 1996;39:1444–1445.
   PubMedGoogle Scholar
• Tincani A, Balestrieri G, Spatola L, Cinquini M, Meroni PL, Roubey RAS. Anticardiolipin and anti beta-2glycoprotein I in the diagnosis of antiphospholipid syndrome. Clin Exp Rheumatol 1998;16:396–402.
   PubMedGoogle Scholar
• Exner T. Some recent developments with lupus anticoagulant. Blood Coagul Fibrinolysis 1994;5:281–289.
   PubMed Web of Science ®Google Scholar
• Tincani A, Meroni PL, Brucato A, Zanussi C, Allegri F, Mantelli P, Cattaneo R, Balestrieri G. Anti-phospholipid and anti-mitochondrial type M5 antibodies in systemic lupus erythematosus. Clin Exp Rheumatol 1985;3:321–326.
   PubMedGoogle Scholar
• Gharavi AE, Mellors RC, Elkon KB. IgG anti-cardiolipin antibodies in murine lupus. Clin Exp Immunol 1989;78: 233–238.
   PubMed Web of Science ®Google Scholar
• Blank M, Krause I, Shoenfeld Y. The contribution of experimental models to our understanding of etiology, pathogenesis and novel therapies in the antiphospholipid syndrome. In: Khamashta M, editor. Hughes Syndrome. Berlin: Springer; 2000. pp 379–388.
   Google Scholar
• Pierangeli SS, Liu XW, Barker JH, Anderson J, Harris EN. Induction of thrombosis in a mouse model by IgG, IgM and IgA immunoglobulins from patients with antiphospholipid syndrome. Thromb Haemostasis 1995;74:1361–1367.
   Google Scholar
• Meroni PL, Raschi E, Testoni C, Tincani A, Balestrieri G, Youinou P. Antiphospholipid/endothelial cell interaction in the pathogenesis of the antiphospholipid syndrome. In: Asherson R, Cervera R, Piette JC, editors. The AntiphospholipidSindrome II. Autoimmune Thrombosis. Amsterdam: Elsevier; 2002. pp 79–91.
   Google Scholar
• Rote NS, Vogt E, DeVere G, Obringer AR. The role of placental trophoblast in the pathophysiology of the antipho-spholipid antibody syndrome. Am J Reprod Immunol 1988;39:125–136.
   Google Scholar
• Di Simone N, Meroni PL, Del Papa N, Raschi E, Caliandro D, De Carolis CS, et al. Antiphospholipid antibodies affect trophoblast gonadotropin secretion and invasiveness by binding directly and through adhered beta2-glycoprotein I. Arthritis Rheum 2000;43: 140–150.
   Google Scholar
• Cervera R, Piette JC, Font J, Khamashta MA, Shoenfeld Y, Camps MT, et al. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum 2002;46:1019–1027.
   PubMed Web of Science ®Google Scholar
• Schulman S, Svenungsson E, Granqvist S. Anticardiolipin antibodies predict early recurrence of thromboembolism and death among patients with venous thromboembolism follow-ing anticoagulant therapy. Duration of anticoagulation study group. Am J Med 1998;104:332–338.
   Google Scholar
• Galli M, Luciani D, Bertolini G, Barbui T. Lupus anti-coagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. Blood 2003;101: 1827–1832.
   PubMed Web of Science ®Google Scholar
• Lockshin MD, Druzin ML, Goei S, Qamar T, Magid MS, Jovanovic L, et al. Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus. N Engl J Med 1985;313:152–156.
   PubMed Web of Science ®Google Scholar
• Lockwood CJ, Romero R, Feinberg RF, Clyne LP, Coster B, Hobbins JC. The prevalence and biologic significance of lupus anticoagulant and anticardiolipin antibodies in a general obstetric population. Am J Obstet Gynecol 1989;161: 369–373.
   PubMed Web of Science ®Google Scholar
• Erkan D, Merril JT, Yazicy Y, Sammaritano L, Buyon JP, Lockshin MD. High thrombosis rate after fetal loss in antiphospholipid syndrome: effective prophylaxis with aspirin. Arthritis Rheum 2001;44:1466–1467.
   PubMed Web of Science ®Google Scholar
• Tincani A, Taglietti M, Biasini C, Frassi M, Gorla R, Balestrieri G. Thromboembolic events after fetal loss in patients with antiphospholipid syndrome: comment on the article by Erkan et al. Arthritis Rheum 2002;46:1126-1127, Discussion 1127.
   Google Scholar
• Taglietti M, Biasini Rebaioli C, Frassi M, Tincani A, Balestrieri G, Fandn D, et al. Long term outcome of 91 patients with primari antiphospholipd syndrome (PAPS). J Autoimmun 2000;15:A93.
   Google Scholar
• Harris EN, Gharavi AE, Loizou S, Derue G, Chan JK, Patel BM, Mackworth-Young CG, Bunn CC, Hughes GR. Cross-reactivity of antiphospholipid antibodies. J Clin Lab Immunol 1985;16:1–6.
   PubMedGoogle Scholar
• Harris EN, Gharavi AE, Wasley GD, Hughes GR. Use of an enzyme-linked immunosorbent assay and of inhibition studies to distinguish between antibodies to cardiolipin from patients with syphilis or autoimmune disorders. J Infect Dis 1988; 157:23–31.
   PubMed Web of Science ®Google Scholar
• Intrator L, Oksenhendler E, Desforges L, Bierling P. Anticardiolipin antibodies in HIV infected patients with or without immune thrombocytopenic purpura. Br J Haematol 1988; 68:269–270.
   PubMedGoogle Scholar
• Canoso RT, Sise HS. Chlorpromazine-induced lupus anti-coagulant and associated immunologic abnormalities. Am J Hematol 1982;13:121–129.
   PubMed Web of Science ®Google Scholar
• Marai I, Gilburd B, Blank M, Shoenfeld Y. Anti-cardiolipin and anti-beta2-glycoprotein I (beta2GP-I) antibody assays as screening for anti-phospholipid syndrome. Hum Antib 2003;12:57–62.
   PubMedGoogle Scholar